Abstract
Operative charts were reviewed in 86 patients with Charcot-Marie-Tooth disease, a condition characterized by chronic muscular denervation. A total of 161 surgical procedures was performed. Major complications were few, and only one operative death occurred, unrelated to anaesthesia. Succinylcholine and malignant hyperthermia triggering agents were used in 41 (48%) and 77 (90%) patients, respectively, without untoward effects. Contrary to previous reports, this survey supports the safe use of succinylcholine and MH triggering agents in this disease.
Résumé
La maladie de Charcot-Marie-Tooth se caractérise par une dénervation musculaire chronique. Les dossiers anesthésiques de 86 patients atteints de cette maladie ont été revus. Les patients avaient subi un total de 161 interventions chirurgicales. Il y à eu peu de complications majeures, et un seul décès périopératoire sans relation avec l’anesthésie. La succinylcholine a été utilisée chez 41 (48%) patients et d’autres agents susceptibles d’induire une hyperthermie maligne ont servi pour anesthésier 77 (90%) patients. Aucun effet indésirable dû à ces médicaments n’a été observé. Contrairement à d’autres observations cliniques, cette étude rétrospective suggère que la succinylcholine et les agents inducteurs d’hyperthermie maligne peuvent être utilisés sans augmenter le risque de complication chez les patients atteints de cette maladie.
Article PDF
Similar content being viewed by others
References
Harding AE, Thomas PK. The clinical features of hereditary motor and sensory neuropathy Types I and II. Brain 1980; 103: 259–80.
Adams RD, Victor M. Principles of Neurology. 3rd ed. New York: McGraw-Hill, 1985; 987–8.
Brian JE, Boyles GD, Quirk JG, Clark RB. Anesthetic management for Cesarean section of a patient with Charcot-Marie-Tooth Disease. Anesthesiology 1987; 66: 410–2.
Roelofse JA, Shipton EA. Anaesthesia for abdominal hysterectomy in Charcot-Marie-Tooth disease. A case report. S Afr Med J 1985; 67: 605–6.
Hirota K, Muraoka M, Sugihara K, Amano N, Matsuki A, Oyama T. Anesthetic experience of a patient with Charcot-Marie-Tooth disease. Masui 1988; 37: 207–10.
Sugai K, Sugai Y. Epidural anesthesia for a patient with Charcot-Marie-Tooth disease, bronchial asthma and hypothyroidism. Masui 1989; 38: 688–91.
Watanabe T, Yamashita M, Kondo Y, et al. Anesthetic and post-operative management of Charcot-Marie-Tooth disease. Masui 1982; 31: 530–4.
Gronert GA, Lambert EH.Theye RA. The response of denervated skeletal muscle to succinylcholine. Anesthesiology 1973; 39: 13–22.
Gronert GA, Theye RA. Pathophysiology of hyperkalemia induced by succinylcholine. Anesthesiology 1975; 43: 89–99.
Cooperman LH. Succinylcholine-induced hyperkalemia in neuromuscular disease. JAMA 1970; 213:1867–71.
Nathanson BN, Yu DG, Chan CK. Respiratory muscle weakness in Charcot-Marie-Tooth disease. A field study. Arch Intern Med 1989; 149: 1389–91.
Laroche CM, Carrol N, Moxham J, Stanley NN, Evans RJC, Green M. Diaphragm weakness in Charcot-Marie-Tooth disease. Thorax 1988; 43: 478–9.
Gilcrist D, Chan CK, Deck JHN. Phrenic involvement in Charcot-Marie-Tooth disease. A pathologic documentation. Chest 1989; 96: 1197–9.
Eichacker PQ, Spiro A, Sherman M, Lazar E, Reichet J, Dodick F. Respiratory muscle dysfunction in hereditary motor sensory neuropathy, Type I. Arch Intern Med 1988; 148: 1739–40.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Antognini, J.F. Anaesthesia for charcot-marie-tooth disease: a review of 86 cases. Can J Anaesth 39, 398–400 (1992). https://doi.org/10.1007/BF03009054
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03009054